Article (Scientific journals)
Very late-onset EBV-related cutaneous post-transplant lymphoproliferative disorder.
Bouillenne, Amandine; Somja, Joan; Absil, Gilles et al.
2025In BMJ Case Reports, 18 (7), p. 265774
Peer Reviewed verified by ORBi
 

Files


Full Text
Very late-onset EBV-related cutaneous post-transplant lymphoproliferative disorder.pdf
Publisher postprint (4.46 MB) Creative Commons License - Attribution, Non-Commercial
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Dermatology; Haematology (incl blood transfusion); Malignant disease and immunosuppression; Renal transplantation; Prednisone; Rituximab; Cyclophosphamide; Doxorubicin; Vincristine; Age of Onset; Immunosuppression Therapy; In Situ Hybridization; Positron Emission Tomography Computed Tomography; Diagnosis, Differential; Humans; Female; Aged; Skin/virology; Prednisone/administration & dosage; Rituximab/administration & dosage; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Vincristine/administration & dosage; Pigmentation; Lymphoproliferative Disorders/virology; Epstein-Barr Virus Infections/virology; Herpesvirus 4, Human/isolation & purification; Kidney Transplantation/adverse effects; Antineoplastic Combined Chemotherapy Protocols; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Kidney Transplantation; Lymphoproliferative Disorders; Skin Neoplasms; Medicine (all)
Abstract :
[en] The Epstein-Barr Virus-related cutaneous post-transplant lymphoproliferative disorder (EBV-cPTLD) is an exceptional complication of the immediate post-transplant period, related to the immunosuppression leading to EBV reactivation. EBV-cPTLD presents a heterogeneous dermatological spectrum complicating the diagnosis, hence requiring histology, immunohistochemistry (IHC) and in situ hybridisation (ISH) for confirmation.A woman in her 70s with a 24 year history of renal transplantation presented atypical infiltrated, hyperpigmented lesions on the left arm and leg along with general health deterioration. Histology, IHC and ISH on skin biopsy demonstrated an EBV-positive infiltration, confirming plasmablastic lymphoma, a form of EBV-cPTLD. A Positron Emission Tomography/Computed Tomography (PET/CT) demonstrated hypermetabolic cutaneous and bone infiltrations that resolved after an rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment.This case illustrates that cPTLD should be included in the differential diagnosis of atypical skin lesions, even decades after transplantation. Although retrieving EBV in late cPTLD is exceptional, this case shows that proliferating EBV can be demonstrated in very late-onset cPTLD.
Disciplines :
Dermatology
Author, co-author :
Bouillenne, Amandine;  Dermatology, Université de Liège Faculté de Médecine, Liège, Belgium abouillenne@student.uliege.be
Somja, Joan  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques
Absil, Gilles ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de dermatologie
Nikkels, Arjen ;  Université de Liège - ULiège > Département des sciences cliniques > Dermatologie
Language :
English
Title :
Very late-onset EBV-related cutaneous post-transplant lymphoproliferative disorder.
Publication date :
28 July 2025
Journal title :
BMJ Case Reports
eISSN :
1757-790X
Publisher :
BMJ Publishing Group, England
Volume :
18
Issue :
7
Pages :
e265774
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 09 September 2025

Statistics


Number of views
29 (0 by ULiège)
Number of downloads
32 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi